Newsletter

Marc Kennis

Marc Kennis is one of the Co-Founders of Stocks Down Under and has been an equities analyst since 1996, predominantly covering Semiconductors, Technology, Consumer Electronics and Medical Equipment. Prior to founding Stocks Down Under, Marc worked for various brokers and banks in the Netherlands, including ING and Rabobank, and co-founded Pitt Street Research in 2016. Marc obtained an MSc in Economics from Tilburg University, Netherlands in 1996 and a postgraduate degree in investment analysis in 2001.

222 articles published Follow:

General

Fleetwood’s (ASX: FWD) share price goes its own way in 2023

Who is Fleetwood? Fleetw oo d Corporation (ASX: FWD) manufactures and sells modular accommodation units in Australia and New Zealand. The company operates through three segments : Building Solutions, Community Solutions and RV Solutions. The Building Solutions segment manufactures and supplies accommodation to education, affordable housing, mining and other industries. The…

ByMarc KennisOctober 19, 20220Comments

Resources

Will Comet Ridge (ASX: COI) be a rising or just a shooting star in 2023?

Comet Ridge (ASX: COI) shares spiked 40% after the company announced a major success with its pilot well in its Mahalo Gas Project, situated near the Bowen Basin, Queensland. The project is a Coal Seam Gas (CSG) play, similar to that of TMK Energy’s Gurvantes CSG Project in Mongolia. We wrote about …

ByMarc KennisOctober 18, 20220Comments

Financials

Bank of Queensland (ASX: BOQ) is banking on the strength of the Australian economy

Bank of Queensland (ASX: BOQ) shares spiked almost 11% yesterday after the company announced its FY22 results : a net profit after tax (NPAT) of $426m, a 15% improvement over FY21 . No time to do stock research, but you still want to invest? Stocks Down Under…

ByMarc KennisOctober 13, 20220Comments

Resources

TMK Energy’s (ASX: TMK) share price is rallying on the back of excellent drilling results

TMK Energy’s (ASX: TMK) share price has had a good time in the last 4 weeks after the company announced successful drilling results from its Gurvantes Coal Seam Gas (CSG) Project , located in the South Gobi Desert in Mongolia. No time to do stock research, but…

ByMarc KennisOctober 12, 20220Comments

Resources

Can Ora Banda Mining’s (ASX: OBM) new boss wipe out the stock’s massive undervaluation?

Ora Banda Mining (ASX: OBM) is an emerging ASX gold producer. Its flagship project is the Davyhurst Gold Project located in the North-West of Kalgoorlie, Western Australia. OBM plans to produce gold from its deposits situated within 50 km of its processing plant at the town of Davyhurst, including Siberia’s open pit…

ByMarc KennisOctober 11, 20220Comments

General

Lynch Group (ASX: LGL) is blossoming in FY23

Lynch Group (ASX: LGL) grows flowers and potted plants in Australia and China, and sells to wholesalers and retailers in those local markets and internationally. The company sells its products through supermarkets, florists, independent retailers and online. To learn more about Lynch Group, Stocks Down Under subscribers can read our article …

ByMarc KennisOctober 6, 20220Comments

General

K&S Corporation (ASX: KSC) has broken out of a 6-year resistance level

Who is K&S Corporation? K&S Corporation (ASX: KSC) is a small logistics company operating in Australia and New Zealand. The company offers transportation, warehousing and fuel distribution services through roads, rail tracks and coastal sea lines. No time to do stock research, but you still want to invest? Stocks…

ByMarc KennisOctober 5, 20220Comments

CleanTech Industrials

Altech Chemicals (ASX: ATC) is flying high on the back of a joint venture deal

Getting exposure to the green energy transition Shares of the emerging high purity alumina (HPA) producer, Altech Chemicals (ASX: ATC), soared in the second half of September after the company announced it ha d signed a joint venture agreement with a German battery institute, Fraunhofer IKTS…

ByMarc KennisOctober 4, 20220Comments

Life Sciences

Actinogen Medical (ASX: ACW): Good news on phase 2 trials can catapult this stock

Working on a new drug for Alzheimer’s disease Actinogen Medical (ASX: ACW) is a Sydney-based biotechnology company working on finding treatments for Alzheimer’s and other neurological diseases. It’s working on a number of drugs, but its Xanamem’s recent clinical developments are what’s got the market excited. No time to do stock research,…

ByMarc KennisSeptember 29, 20220Comments

Industrials

Viva Energy (ASX: VEA) is firing on all cylinders

Keeping Australia humming Viva Energy Group (ASX: VEA) is one of the largest energy companies in Australia, supplying about 25% of the country’s need for liquid fuel. Its major business segments are Retail, Fuels & Marketing (RFM) and Refining. No time to do stock research, but you still want…

ByMarc KennisSeptember 28, 20220Comments